Upgrade to SI Premium - Free Trial

Amgen (AMGN) Thoughts After Ph1 Data - Mizuho

September 9, 2019 7:53 AM
Mizuho Securities analyst Salim Syed reiterated a Neutral rating and $212.00 price target on Amgen (NASDAQ: AMGN) after the company ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles